A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects
Clinical trial NCT01205737 · COMPLETED
Trial details
- NCT number
- NCT01205737
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-07-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.